Respire_final-01
  • CORPORATE
    • Company Overview
    • Board of Directors
    • RespireRx Organization Structure
    • Social Media Guidelines
  • NEUROTRANSMISSION
  • RESOLUTIONRX
    • Cannabinoid Platform Summary
    • Pharmaceutical Cannabinoids
    • Obstructive Sleep Apnea
    • Dronabinol for the Treatment of Obstructive Sleep Apnea
    • Regulatory Process
  • ENDEAVOURRX
    • Neuromodulators
    • Ampakines
      • AMPAkine Platform Summary
      • Lead Compounds
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Spinal Cord Injury (SCI)
    • GABAkines
      • GABAkines Platform Summary
      • Background
      • Epilepsy
      • Pain
  • PRODUCT PIPELINE
  • INVESTORS
    • Investor Contact
    • SEC Reports
    • News
    • FAQs
    • Presentations
  • CONTACT

Investor Contact

RespireRx invites any and all inquiries pertaining to corporate information and investment opportunities. You’ll find the appropriate contact agents listed below.

Jeff Margolis
Senior Vice President, Chief Financial Officer, Secretary, Treasurer and member of Board of Directors
RespireRx Pharmaceuticals Inc.
126 Valley Road, Suite C
Glen Rock, New Jersey 07452
(917) 834-7206
jmargolis@respirerx.com

  • Investor Contact
  • SEC Reports
  • News
  • FAQs
  • Presentations
©2016 RespireRx Phamaceuticals Inc. All Rights Reserved.